Shares of Pfizer Inc. and other biotech drug makers fell in the extended session Friday after Pfizer slashed $9 billion in expected sales from its full-year…
Shares of Pfizer Inc. and other biotech drug makers fell in the extended session Friday after Pfizer slashed $9 billion in expected sales from its full-year…
It’s likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna Inc.…